PARIS/LONDON (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday. Plavix, ...

LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...

Clopidogrel is prescribed to help prevent heart attack or stroke. It's a generic medication and is available as the brand-name drug Plavix. It comes as an oral tablet. The cost of clopidogrel can vary ...

News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix®, ...

A former senior vice-president at Bristol-Myers Squibb has been charged by the US Department of Justice with lying to federal authorities over a deal struck with rival generics maker Apotex. According ...

The US Food and Drug Administration (FDA) announced it has approved eleven generic versions of Bristol-Myers Squibb and Sanofi's blockbuster blood-thinner Plavix (clopidogrel bisulfate), marking the ...

This year, Peter R. Dolan, the CEO of Bristol-Myers Squibb, was faced with the threat of generic competition for Plavix, an anti-clotting drug with $3.2 billion in annual U.S. sales. In responding to ...

HOST-EXAM trial, a landmark study recently released at the ACC 2026. The trial sought to determine the effectiveness of ...

Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...